BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6114477)

  • 1. [Autologous haematopoietic stem cell transplantation. Preliminary results of a regional multicentric study (author's transl)].
    Herve P; Rozenbaum A; Plouvier E; Lamy B; Flesh M; Farradji A; Bergerat JP; Adjizian JC; Behar C; Vu Van H; Philip T
    Nouv Presse Med; 1981 May; 10(24):2001-6. PubMed ID: 6114477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
    Vellenga E; van Putten WL; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Jonkhoff AR; Huijgens PC; Verdonck LF; van der Lelie J; Schouten HC; Gmür J; Wijermans P; Gratwohl A; Hess U; Fey MF; Löwenberg B
    Bone Marrow Transplant; 1999 Jun; 23(12):1279-82. PubMed ID: 10414916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
    Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
    Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
    Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
    Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
    de la Rubia J; Sanz GF; Martín G; Sempere A; Picón I; Carral A; Larrea L; Martínez J; Soler MA; Bonanad S; López F; Jarque I; Sanz MA
    Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow transplantation in acute myeloid leukemia in relapse or in complete remission.
    Herve P; Rozenbaum A; Plouvier E; Flesch M; Cahn JY; Farradji A; Bergerat JP; Adjizian JC; Pignon B
    Cancer Treat Rep; 1982 Nov; 66(11):1983-5. PubMed ID: 6754076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
    Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous stem cell transplantation. From bone marrow to selected blood stem cells: 100 consecutive procedures at a single center].
    Geisler CH; Simonsen AC; Mortensen BT; Christensen LD; Ersbøll JK; Andersen NS; Dickmeiss E; Hansen MM
    Ugeskr Laeger; 1996 Apr; 158(18):2546-51. PubMed ID: 8686009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia.
    Lowdell MW; Ray N; Craston R; Corbett T; Deane M; Prentice HG
    Bone Marrow Transplant; 1997 May; 19(9):891-7. PubMed ID: 9156262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow/stem cell transplantation: initial experience at a north Indian referral centre.
    Gupta S; Kumar L; Raju GM; Kochupillai V; Shukla DK
    Natl Med J India; 2000; 13(2):61-6. PubMed ID: 10835851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
    Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
    Richel DJ; Baars JW; Wijngaarden MJ; van der Schoot CE; Vlasveld LT; Rodenhuis S
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):245-50. PubMed ID: 7679478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results in non randomized patients with acute myelogenous leukemia: a single institution experience.
    Deliliers GL; Annaloro C; Oriani A; Della Volpe A; Boschetti C; Cortelezzi A; Maiolo AT
    Ann Ital Med Int; 1998; 13(3):146-51. PubMed ID: 9859570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood stem cells collected in very early remission produce rapid and sustained autologous haemopoietic reconstitution in acute non-lymphoblastic leukaemia.
    To LB; Dyson PG; Branford AL; Russell JA; Haylock DN; Ho JQ; Kimber RJ; Juttner CA
    Bone Marrow Transplant; 1987 Jun; 2(1):103-8. PubMed ID: 2901874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of autologous peripheral blood stem cell transplantation in children with malignant tumor.
    Tang S; Huang D; Wang J; Wei X; Ran C; Peng Y; Lu S; Zhang J
    Chin Med J (Engl); 2001 Oct; 114(10):1098-101. PubMed ID: 11677775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.